PMC first in Ky. to deliver technology to treat arrhythmia
PIKEVILLE, Ky. — On Feb. 25, Pikeville Medical Center Heart and Vascular Institute conducted Kentucky’s first ablation procedure using the newly FDA-approved Tacti-Cath Contact Force Ablation Catheter, Sensor Enabled, produced by Abbott.
This procedure is a major advancement for physicians, helping them to precisely model the heart and improve the lives of people living with complex arrhythmias, the hospital said in a news release.
“We are proud to be the first hospital in Kentucky, and one of the first 25 in the country, to have access to this exciting new technology,” said PMC electrophysiologist Dr. Chase Reynolds. “The fact that Abbott Medical chose PMC as one of the first hospitals to use this new catheter demonstrates the reputation that the electrophysiology program at PMC has established.”
Reynolds says the new catheter allows him and PMC electrophysiologist and director of Cardiology Services Dr. Michael Antimisiaris to perform ablations with increased efficacy and safety. An ablation is defined as a procedure to scar or destroy tissue in a heart that’s allowing incorrect electrical signals to cause an abnormal heart rhythm.
“This is just another way that PMC is making sure that our patients have access to the best medical care available,” Reynolds said.
A cardiac arrhythmia is an abnormal heart rhythm that typically develops when disease or injury disrupts the heart’s electrical signals, causing the heart to beat erratically. AFib can affect how efficiently the heart pumps blood through the body, causing symptoms such as dizziness, shortness of breath or lightheadedness. The condition can also increase a person’s risk of stroke.
An estimated 2.7 million to 6.1 million Americans have AFib, according to the Centers for Disease Control and Prevention (CDC).
For more information, visit www.pikevillehospital.org.